(Q41210248)

28 September 2017

title

Bioavailability of iron in hemodialysis patients treated with erythropoietin: evidence for the inhibitory role of aluminum (English)

1 reference

28 September 2017

0 references

1 reference

1 reference

Donnelly SM

1

1 reference

28 September 2017

Ali MA

series ordinal

2

1 reference

28 September 2017

Churchill DN

series ordinal

3

1 reference

28 September 2017

publication date

1 November 1990

1 reference

American Journal of Kidney Diseases

28 September 2017

published in

1 reference

28 September 2017

volume

16

1 reference

28 September 2017

issue

5

1 reference

28 September 2017

page(s)

447-451

1 reference

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980057-6

7 January 2021

Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980057-6

7 January 2021

Plasma aluminum is bound to transferrin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980057-6

7 January 2021

Aluminum inhibits erythropoiesis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980057-6

7 January 2021

Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980057-6

7 January 2021

An automated micromethod for measuring iron concentration in serum using thioglycollic acid and bathophenantroline sulphonate

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980057-6

7 January 2021

Trace analysis of lead in blood, aluminium and manganese in serum and chromium in urine by graphite furnace atomic absorption spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980057-6

7 January 2021

The anaemia of chronic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980057-6

7 January 2021

The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980057-6

7 January 2021

Evaluation of iron status in patients on chronic hemodialysis: relative usefulness of bone marrow hemosiderin, serum ferritin, transferrin saturation, mean corpuscular volume and red cell protoporphyrin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980057-6

7 January 2021

Effect of aluminum on porphyrin metabolism in hemodialyzed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980057-6

7 January 2021

The role of aluminum in the functional iron deficiency of patients treated with erythropoietin: case report of clinical characteristics and response to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980057-6

7 January 2021

10.1016/S0272-6386(12)80057-6

Identifiers

DOI

1 reference

28 September 2017

1 reference